HOOK
Companies
NASDAQ
Hookipa Pharma Inc.
Health Care
$1.31
-$0.70 (-35.07%)
Price Chart
Overview
About HOOK
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
Market Cap
$81.0M
Volume
68.4K
Avg. Volume
81.0K
P/E Ratio
-0.14922652
Dividend Yield
0.00%
Employees
128.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.38
High Correlation
Volatility
High (0.80)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, HOOK shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$81.0M
Volume68.4K
P/E Ratio-0.15
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 28, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025